The heterologous expression of the reverse transcriptase from the Avian Myeloblastosis
Virus (AMV-RT) in prokaryotic cells and in particular Escherichia coli (E.
coli) is described in the present invention. The invention also includes certain
measures to simplify the purification of the heterodimeric AMV-RT.
